Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis

被引:60
|
作者
Rubins, A
Gutmane, R
Valdmane, N
Stevenson, P
Foster, C
Undre, N
机构
[1] Fujisawa GmbH, D-81673 Munich, Germany
[2] Latvijas Dermatol Inst, Riga, Latvia
关键词
adults; atopic dermatitis; pharmacokinetics; tacrolimus ointment;
D O I
10.1111/j.0022-202X.2005.23754.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The systemic exposure to tacrolimus after first and repeated application of 0.1% tacrolimus ointment was investigated in 32 adults with moderate to severe atopic dermatitis. Patients were allocated to treatment groups according to the size of the affected area to be treated: Group 1 <= 3000 cm(2) (N = 11); Group 2 > 3000 cm(2) <= 6000 cm(2) (N = 12); Group 3 > 6000 cm(2) <= 10,000 cm(2) (N = 9). Ointment was applied twice daily for 13 d and once daily on Day 14; the size of application area remained the same irrespective of healing. Blood samples were collected on Days 1 (first application), 4, and 14 (last application) and analyzed by a validated HPLC-MS/MS method. Systemic exposure to tacrolimus was generally low with 96% of blood samples assayed containing concentrations below 1 ng per mL and 23% of samples below the lower limit of quantification (0.025 ng per mL). Peak concentrations after first ointment application were <= 2.8 ng per mL, and the mean area under the concentration-time curve between 0 and 12 h using the trapezoidal rule (AUCO-12) values were 1.1, 1.6, and 4.8 ng h per mL for Groups 1, 2, and 3, respectively. The corresponding mean values on Day 14 were similar indicating negligible systemic accumulation of tacrolimus after repeated ointment applications. Both the rate and extent of topical absorption decreased as the skin lesions healed.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 50 条
  • [1] Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis
    Undre, N. A.
    Moloney, F. J.
    Ahmadi, S.
    Stevenson, P.
    Murphy, G. M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (03) : 665 - 669
  • [2] A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis
    Harper, J
    Smith, C
    Rubins, A
    Green, A
    Jackson, K
    Zigure, S
    Bourke, J
    Alomar, A
    Stevenson, P
    Foster, C
    Undre, N
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : 695 - 699
  • [3] Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis
    Wollenberg, A.
    Sidhu, M. K.
    Odeyemi, I.
    Dorsch, B.
    Koehne-Volland, R.
    Schaff, M.
    Ehlken, B.
    Berger, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1322 - 1330
  • [4] The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis
    Reitamo, Sakari
    Mandelin, Johanna
    Rubins, Andris
    Remitz, Anita
    Maekelae, Mika
    Cirule, Kristine
    Rubins, Silvestrs
    Zigure, Sanita
    Ho, Vincent
    Dickinson, James
    Undre, Nasrullah
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (04) : 348 - 355
  • [5] Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
    Wollenberg, A.
    Reitamo, S.
    Atzori, F.
    Lahfa, M.
    Ruzicka, T.
    Healy, E.
    Giannetti, A.
    Bieber, T.
    Vyas, J.
    Deleuran, M.
    [J]. ALLERGY, 2008, 63 (06) : 742 - 750
  • [6] Tacrolimus ointment (TO) for adults with moderate to severe atopic dermatitis (AD): A dose escalation study.
    Kang, S
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 681 - 681
  • [7] Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis
    Draelos, ZD
    Hanifin, J
    Chon, K
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P4 - P4
  • [8] Tacrolimus ointment with and without topical steroids in patients with moderate to severe atopic dermatitis
    Breneman, D
    Fleischer, A
    Abramovits, W
    Farber, H
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB88 - AB88
  • [9] COST-UTILITY ANALYSIS OF MAINTENANCE TREATMENT WITH TACROLIMUS OINTMENT IN ADULTS AND CHILDREN WITH MODERATE AND SEVERE ATOPIC DERMATITIS
    Chambers, C.
    Bentley, A.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A147 - A147
  • [10] Tacrolimus pharmacokinetics in adult and pediatric atopic dermatitis patients following topical application of tacrolimus ointment
    Krueger, G
    Eichenfield, L
    Holum, ME
    Keirns, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB88 - AB88